574 related articles for article (PubMed ID: 14749350)
21. Transcriptome analysis of complex I-deficient patients reveals distinct expression programs for subunits and assembly factors of the oxidative phosphorylation system.
van der Lee R; Szklarczyk R; Smeitink J; Smeets HJ; Huynen MA; Vogel R
BMC Genomics; 2015 Sep; 16():691. PubMed ID: 26369791
[TBL] [Abstract][Full Text] [Related]
22. Molecular base of biochemical complex I deficiency.
Hoefs SJ; Rodenburg RJ; Smeitink JA; van den Heuvel LP
Mitochondrion; 2012 Sep; 12(5):520-32. PubMed ID: 22820119
[TBL] [Abstract][Full Text] [Related]
23. Leber hereditary optic neuropathy mutations in the ND6 subunit of mitochondrial complex I affect ubiquinone reduction kinetics in a bacterial model of the enzyme.
Pätsi J; Kervinen M; Finel M; Hassinen IE
Biochem J; 2008 Jan; 409(1):129-37. PubMed ID: 17894548
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial complex I is deficient in renal oncocytomas.
Simonnet H; Demont J; Pfeiffer K; Guenaneche L; Bouvier R; Brandt U; Schagger H; Godinot C
Carcinogenesis; 2003 Sep; 24(9):1461-6. PubMed ID: 12844484
[TBL] [Abstract][Full Text] [Related]
25. Respiratory active mitochondrial supercomplexes.
Acín-Pérez R; Fernández-Silva P; Peleato ML; Pérez-Martos A; Enriquez JA
Mol Cell; 2008 Nov; 32(4):529-39. PubMed ID: 19026783
[TBL] [Abstract][Full Text] [Related]
26. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency.
Willems PH; Valsecchi F; Distelmaier F; Verkaart S; Visch HJ; Smeitink JA; Koopman WJ
Cell Calcium; 2008 Jul; 44(1):123-33. PubMed ID: 18295330
[TBL] [Abstract][Full Text] [Related]
28. Understanding mitochondrial complex I assembly in health and disease.
Mimaki M; Wang X; McKenzie M; Thorburn DR; Ryan MT
Biochim Biophys Acta; 2012 Jun; 1817(6):851-62. PubMed ID: 21924235
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of the nuclear-encoded subunits of the complexes III and IV disrupts their respective complexes but not complex I in procyclic Trypanosoma brucei.
Horváth A; Horáková E; Dunajcíková P; Verner Z; Pravdová E; Slapetová I; Cuninková L; Lukes J
Mol Microbiol; 2005 Oct; 58(1):116-30. PubMed ID: 16164553
[TBL] [Abstract][Full Text] [Related]
30. The oxidative phosphorylation (OXPHOS) system: nuclear genes and human genetic diseases.
van den Heuvel L; Smeitink J
Bioessays; 2001 Jun; 23(6):518-25. PubMed ID: 11385631
[TBL] [Abstract][Full Text] [Related]
31. Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations.
Rubio-Gozalbo ME; Dijkman KP; van den Heuvel LP; Sengers RC; Wendel U; Smeitink JA
Hum Mutat; 2000; 15(6):522-32. PubMed ID: 10862082
[TBL] [Abstract][Full Text] [Related]
32. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
[TBL] [Abstract][Full Text] [Related]
33. Leigh disease with brainstem involvement in complex I deficiency due to assembly factor NDUFAF2 defect.
Herzer M; Koch J; Prokisch H; Rodenburg R; Rauscher C; Radauer W; Forstner R; Pilz P; Rolinski B; Freisinger P; Mayr JA; Sperl W
Neuropediatrics; 2010 Feb; 41(1):30-4. PubMed ID: 20571988
[TBL] [Abstract][Full Text] [Related]
34. Respiratory chain complex I deficiency.
Triepels RH; Van Den Heuvel LP; Trijbels JM; Smeitink JA
Am J Med Genet; 2001; 106(1):37-45. PubMed ID: 11579423
[TBL] [Abstract][Full Text] [Related]
35. [Application of new techniques for locating the underlying molecular defects in patients with disorders of oxidative phosphorylation].
Van Coster R; Smet J
Verh K Acad Geneeskd Belg; 2007; 69(4):197-211. PubMed ID: 17821958
[TBL] [Abstract][Full Text] [Related]
36. Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice.
Edgar D; Shabalina I; Camara Y; Wredenberg A; Calvaruso MA; Nijtmans L; Nedergaard J; Cannon B; Larsson NG; Trifunovic A
Cell Metab; 2009 Aug; 10(2):131-8. PubMed ID: 19656491
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial cytopathies and neuromuscular disorders.
Van Coster R; De Meirleir L
Acta Neurol Belg; 2000 Sep; 100(3):156-61. PubMed ID: 11098288
[TBL] [Abstract][Full Text] [Related]
38. An introduction: oxidative phosphorylation diseases.
Shoffner JM
Semin Neurol; 2001 Sep; 21(3):237-50. PubMed ID: 11641814
[TBL] [Abstract][Full Text] [Related]
39. Complex I deficiency in Persian multiple sclerosis patients.
Kumleh HH; Riazi GH; Houshmand M; Sanati MH; Gharagozli K; Shafa M
J Neurol Sci; 2006 Apr; 243(1-2):65-9. PubMed ID: 16413582
[TBL] [Abstract][Full Text] [Related]
40. Progressive encephalopathy and complex I deficiency associated with mutations in MTND1.
Moslemi AR; Darin N; Tulinius M; Wiklund LM; Holme E; Oldfors A
Neuropediatrics; 2008 Feb; 39(1):24-8. PubMed ID: 18504678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
